Immunic Names Jaa Roberson as Chief People Officer

Immunic, Inc., a biotechnology company advancing oral therapies for neurologic diseases, has announced Jaa Roberson as the new Chief People Officer. Effective immediately, she joins the executive leadership team, reporting to CEO Erik Lundgren. This strategic appointment aligns with Immunic's vision of becoming a leading multiple sclerosis organization as it transitions towards a fully integrated commercial entity.

Roberson will lead global talent and organizational strategies, focusing on acquiring specialized talent in anticipation of the Phase 3 ENSURE read-out by the end of 2026. Her role is crucial as Immunic prepares for regulatory filings and the commercialization of vidofludimus calcium (IMU-838).

Roberson brings over two decades of HR expertise, notably aiding companies in transformation and commercial growth. Previously, as CPO at Day One Biopharmaceuticals, she played a pivotal role in expanding the company and its pipeline, overseeing significant acquisitions and transitions.